trial · primary record
SHR-4595 for Injection
Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 208 |
| Primary completion | 2030-12 |
| Primary endpoint | Adverse events (AEs) |
| Registry ID | NCT07830199 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:53.033Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07830199
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.